STARTUP PROFILE

Neurolief

COUNTRY
Israel
FOUNDED
2014
CATEGORY
Neuromodulation
Delivers wearable, at-home neuromodulation via Relivion, stimulating multiple cranial nerve branches to relieve migraine and depression.
Visit website →
Neurofounders Insights
$   Funding   -
Seed
MODALITY
Nerve stimulator
FORM FACTOR
Headset/cap
INTERFACE DEPTH
Non-invasive
INDICATION
Psychiatry
TARGET USER
Patients
REGULATORY STAGE
FDA approved (PMA)
Neurolief is differentiated by its multi-branch cranial nerve stimulation headset, positioning Relivion as a more distributed neuromodulation approach than single-nerve wearables. Its approval pathway and at-home use case give it stronger commercial grounding than many consumer-adjacent stimulation products.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Neurolief